Anrate Recombinant Human Albumin: Redefining the Future of Cell Therapy, Ushering in a New Era of Biomedicine
With the rapid advancement of biomedicine and regenerative medicine, cell therapy has emerged as a disruptive technology for combating tumors and repairing tissue damage. As the "source of life" for cell culture, the quality of culture medium directly determines therapeutic efficacy and industrialization progress. Leveraging world‑leading technological breakthroughs and full‑scenario application advantages, Anrate Recombinant Human Albumin (rHSA) is leading the industry to new heights of safety, efficiency and standardization as an innovator.
I.Global‑Leading Technology, Setting Industry Benchmarks
1. Ultra‑High Purity & Zero‑Contamination Assurance
Anrate adopts a recombinant Pichia pastoris expression system and multiple precision purification processes, achieving product purity above 99.999999%, far exceeding international standards. Adopting animal‑free and serum‑free production processes, it completely eliminates risks of pathogen and viral contamination, building a solid biosafety barrier for cell therapy.
2. Superior Stability & Versatile Functionality
Manufactured under a GMP‑compliant system, Anrate rHSA exhibits exceptional thermal and chemical stability. It precisely regulates the osmotic pressure and pH value of culture media, while efficiently binding and transporting key molecules such as fatty acids, metal ions and cytokines, providing sustained nutritional support and antioxidant protection for cells.
3. Large‑Scale Production Empowering Global Supply
As the world’s first approved recombinant human albumin injection (market‑authorized in Russia and Kyrgyzstan), Anrate runs the world’s largest production line with an annual output of 50 tons, with a planned future annual capacity of 600 tons. It fundamentally addresses the challenges of blood‑source dependence and supply shortage.
II. Full‑Scenario Applications, Empowering the Entire Lifecycle of Cell Therapy
1. Unique Advantages in NK Cell Culture
(1) Accelerating NK Cell Expansion and Enhancing Cell Viability
In the field of immunotherapy, natural killer (NK) cells are highly valued for their capacity to rapidly recognize and eliminate abnormal cells. When incorporated into NK cell culture media, Anrate Recombinant Human Albumin effectively accelerates rapid NK cell expansion by optimizing the cellular microenvironment and reducing oxidative stress and apoptosis rates. Experimental data demonstrate that culture media supplemented with Anrate albumin delivers faster NK cell expansion compared with conventional culture systems, alongside significantly improved cell survival rate and viability indicators.
(2) Boosting Cytotoxicity and Improving Immune Killing Efficiency
Studies have shown that supplementation of recombinant human albumin in culture media effectively improves the metabolic status of NK cells, thereby facilitating their cytotoxic functions. By enhancing cell membrane stability and energy supply, Anrate products enable NK cells to exhibit higher killing efficiency against tumor cells and virus‑infected cells, providing robust cell‑based products for clinical immunotherapy.
(3) Simplifying Culture Systems and Reducing Process Complexity
Traditional cell culture often relies on complex serum components, which introduces uncertainties into culture systems and raises production costs. The addition of Anrate Recombinant Human Albumin enables simpler and more standardized culture workflows. By reducing dependence on animal serum, it lowers batch‑to‑batch variability and brings the entire cell culture process into greater GMP compliance, laying a solid technical foundation for large‑scale industrial production.
III. Data‑Validated, a Globally Trusted Choice
Numerous experiments and real‑world application cases have fully proven the outstanding performance of Anrate Recombinant Human Albumin in the culture of NK cells and stem cells.
NK Cell Expansion Assays: Independent verifications across multiple laboratories show that culture media containing Anrate products achieve higher NK cell expansion folds than conventional serum‑based culture systems. Furthermore, cytotoxicity tests indicate that NK cells cultured with Anrate exhibit greater specificity and efficiency in killing tumor cells and virus‑infected cells.
Serum‑Free MSC Culture Assays: Under serum‑free conditions, MSC (Mesenchymal Stem Cell) culture media supplemented with Anrate Recombinant Human Albumin maintain a cell survival rate above 90%. Meanwhile, the cells retain multilineage differentiation potential during long‑term culture, ensuring stable and balanced differentiation outcomes in subsequent differentiation experiments.
Cell Cryopreservation and Thawing: Anrate products also deliver remarkable results when used in cell cryopreservation solutions. Test results demonstrate that cells treated with Anrate achieve far higher survival rates and functional recovery after cryopreservation and thawing compared with traditional cryoprotectants, greatly improving the safety of cell storage and transportation.
From scientific research to clinical translation, Anrate Recombinant Human Albumin has become an indispensable cornerstone in the field of cell culture, providing robust and reliable technical support for global biopharmaceutical enterprises and research institutions. Whether for cell expansion, function maintenance or cryopreservation protection, Anrate offers an unprecedented application experience for researchers through superior product performance and strict quality control, facilitating higher‑level cell therapy and precision medicine goals.
IV. Anrate: Forging the Future with Ingenuity
As an achievement of China’s national key special projects under the 12th and 14th Five‑Year Plans, Anrate has focused on recombinant human albumin for more than a decade. It has overcome core technologies including glycosylation control and ultra‑large‑scale purification, with product purity nearly 1,000 times higher than comparable Japanese counterparts. Supported by a 10,000‑ton‑scale production base and global layout, Anrate will keep expanding into cutting‑edge sectors such as cell therapy, co‑building a new precision‑medicine ecosystem together with global partners.
Product Information:
| Product Namber |
Product Name |
formulation |
Purity |
Specifications |
| ART101S-10g |
Recombinant Human Albumin |
Solid Powder |
＞99% |
10g |
| ART101S-100g |
Recombinant Human Albumin |
Solid Powder |
＞99% |
100g |
| ART101L-10g |
Recombinant Human Albumin |
Liquid Solution |
＞99% |
10g(50ml) |
| ART101L-100g |
Recombinant Human Albumin |
Liquid Solution |
＞99% |
10g(500ml) |
|
ART103S-10g
|
Recombinant Human Albumin |
Solid Powder |
＞99% |
10g |
| ART103S-100g |
Recombinant Human Albumin |
Solid Powder |
＞99% |
100g |
| ART103L-10g |
Recombinant Human Albumin |
Liquid Solution |
＞99% |
10g(50ml) |
| ART103L-100g |
Recombinant Human Albumin |
Liquid Solution |
＞99% |
10g(500ml) |
Ablout US
Beijing Anrate Biotechnology Co., Ltd. is granted global sales qualification by Tonghua Anrate. We are engaged in the marketing promotion and sales of cell‑culture protein products such as recombinant human albumin and recombinant transferrin. Our main products are recombinant human albumin and transferrin.
Important Notice
This product is intended solely for scientific research, laboratory and production purposes. It is not for clinical treatment and shall not be used on animals or humans.
Feel free to contact us
WhatsApp: +85363312841 | Email: sales@bjanrate.cn
Your message must be between 20-3,000 characters!
english
français
Deutsch
Italiano
Русский
Español
português
Nederlandse
ελληνικά
日本語
한국
العربية
हिन्दी
Türkçe
indonesia
tiếng Việt
ไทย
বাংলা
فارسی
polski
